Trial
NCT04447729
A Study to Test if Fremanezumab Reduces Pain in Patients With Interstitial Cystitis-Bladder Pain Syndrome
Phase IIWITHDRAWNOTHER/UNKNOWNConfidence: LOW
Sponsor
Teva Branded Pharmaceutical Products R&D, Inc.
Collaborators
—
Condition
Interstitial Cystitis
Intervention
fremanezumab
Why stopped
Withdrawn due to logistic reasons
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2021-11-09